The aim of this clinical trial study is to compare the efficacy of vaginal misoprostol and isoniazid for cervical ripening prior to hysteroscopy surgery. Inclusion criteria: postmenopausal women and premenopausal women who have no history of vaginal delivery, not pregnant at the time of examination, no contraindication for receiving prostaglandin, no severe vaginal prolapse , no previous surgery on cervix or cervical incompetence. Exclusion criteria: history of vaginal delivery, pregnancy, severe vaginal prolapse, previous surgery on cervix, history of cervical insufficiency, simultaneous laparoscopy and cervical myoma. After confirming the inclusion criteria and obtaining the written informed consent, they randomly assigned to one of two groups, either receiving 400 micrograms of misoprostol vaginally or 3 tablets of 300 mg isoniazid 10-12 hours before operation. The way of randomization into two groups, randomly using Excel software for it. Also to blinding of patients and researchers, used of hide the sealed envelopes. The primary outcomes of the study is interring the hysteroscopy without cervical dilation, and secondary outcomes are number and percentage of patients requiring cervical dilatation, maximum Hagar size interring without force and the side effects. Eventually these outcomes compare in two groups. The sample size in each group is 50 people.